Overview

Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.
Phase:
Phase 3
Details
Lead Sponsor:
MEDRx USA, Inc.
Treatments:
Etodolac
Lidocaine